MILLENNIUM MANAGEMENT LLC

Position in CADL — Candel Therapeutics, Inc.

CIK 1273087 NEW YORK, NY

Position in CADL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,267,221

+$6,072,800 QoQ

Shares Held

1,093,905

+3.2% QoQ

Ownership

1.43%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#10

of 138 holders

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. CADL ranks #98 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	468,410	$232,673,299
2	INSM	INSMED Inc	2,048,005	$218,358,293
3	APGE	Apogee Therapeutics, Inc.	1,491,404	$197,954,052
4	JAZZ	Jazz Pharmaceuticals plc	763,880	$184,072,163
5	ONC	BeOne Medicines Ltd.	543,323	$154,830,755
6	AXSM	Axsome Therapeutics, Inc.	556,088	$136,113,659
7	BMRN	Biomarin Pharmaceutical Inc	2,071,816	$118,549,311
8	REGN	Regeneron Pharmaceuticals, Inc.	165,120	$102,958,924

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,267,221	1,093,905	+3.2%	Shares	Sole	2026-08-14
2026-03-31	$5,194,421	1,060,086	+675.7%	Shares	Sole	2026-05-15
2025-09-30	$697,017	136,670	-34.5%	Shares	Sole	2025-11-14
2025-03-31	$1,178,640	208,609	+559.6%	Shares	Sole	2025-05-15
2024-12-31	$274,513	31,626	+130.6%	Shares	Sole	2025-02-14
2024-09-30	$95,024	13,712	-20.9%	Shares	Sole	2024-11-14
2024-06-30	$107,532	17,344	+16.8%	Shares	Sole	2024-08-14
2022-09-30	$46,610	14,844	+13.3%	Shares	Sole	2022-11-14
2021-12-31	$102,488	13,106	+23.1%	Shares	Sole	2022-02-14
2021-09-30	$115,402	10,646	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.